{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:36:15Z","timestamp":1789475775076,"version":"build-2803163510"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although the genetic background of Dravet syndrome (DS) has been determined and is clearly described, and genetics tests that support a clinical diagnosis are available, DS diagnosis is often based on the clinical assessment alone, which may lead to a late or missed diagnosis. This study explores experiences of caregivers\u2019 of persons with DS with the diagnostic odyssey and their perception of its consequences for DS patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>106 family caregivers connected with the Association for People with Severe Refractory Epilepsy DRAVET.PL completed an anonymised, self-administered, computer-assisted online survey on parents\u2019 experiences of the diagnostic journey conducted from March to June 2024. Although 96.2% of DS parents reported that their children experienced initial symptoms in the first year of life, 58.4% indicated that it took more than a year before DS was diagnosed and 72.7% reported that their DS child received at least one misdiagnosis. While 6.6% of patients were diagnosed by the first doctor consulted, 65.1% had to consult between two and four specialists and 22.8% consulted more than five specialists. 19.8% of parents confirmed that they sought diagnosis abroad. 58.4% of DS parents suggested that delayed diagnosis was harmful to their children\u2019s health. Many believed that it resulted in taking unnecessary or inappropriate medications (67%), hospitalisations (32.1%), or medical interventions (15.1%). Many parents reported problems with accessing genetic counselling and psychological support.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Since DS parents report the multifaceted and protracted diagnostic journey in their children, underscoring the duration of the diagnostic process, numerous misdiagnoses and the number of healthcare professionals involved in achieving the confirmed DS diagnosis, this study highlights the need for widespread access to genetic testing, which usually concludes the diagnostic odyssey and is crucial for managing the proper treatment plan for DS patients. It also shows the need to increase general practitioners\u2019 awareness of the developmental and epileptic encephalopathy (DEE) and the creation of more rapid and transparent referral procedures for children with DEE.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-03772-7","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T07:45:29Z","timestamp":1747381529000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Caregivers\u2019 experiences and challenges of the diagnostic odyssey in Dravet syndrome"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9710-832X","authenticated-orcid":false,"given":"Jan","family":"Domaradzki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8874-2401","authenticated-orcid":false,"given":"Dariusz","family":"Walkowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Association for People with Severe Refractory Epilepsy Dravet.pl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"issue":"Suppl 2","key":"3772_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1528-1167.2011.02994.x","volume":"52","author":"C Dravet","year":"2011","unstructured":"Dravet C. The core Dravet syndrome phenotype. Epilepsia. 2011;52(Suppl 2):3\u20139.","journal-title":"Epilepsia"},{"issue":"Suppl 2","key":"3772_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1469-8749.2011.03964.x","volume":"53","author":"C Dravet","year":"2011","unstructured":"Dravet C. Dravet syndrome history. Dev Med Child Neurol. 2011;53(Suppl 2):1\u20136.","journal-title":"Dev Med Child Neurol"},{"key":"3772_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.seizure.2016.10.014","volume":"44","author":"S Gataullina","year":"2017","unstructured":"Gataullina S, Dulac O. From genotype to phenotype in Dravet disease. Seizure. 2017;44:58\u201364.","journal-title":"Seizure"},{"key":"3772_CR4","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1111\/epi.17274","volume":"63","author":"EC Wirrell","year":"2022","unstructured":"Wirrell EC, Hood V, Knupp KG, Meskis MA, Nabbout R, Scheffer IE, et al. International consensus on diagnosis and management of Dravet syndrome. Epilepsia. 2022;63:1761\u201377.","journal-title":"Epilepsia"},{"key":"3772_CR5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1528-1167.2010.02885.x","volume":"52","author":"B Tro-Baumann","year":"2011","unstructured":"Tro-Baumann B, von Spiczak S, Lotte J, Bast T, Haberlandt E, Sassen R, et al. A retrospective study of the relation between vaccination and occurrence of seizures in Dravet syndrome. Epilepsia. 2011;52:175\u20138.","journal-title":"Epilepsia"},{"key":"3772_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.pediatrneurol.2016.01.011","volume":"58","author":"PTY Wong","year":"2016","unstructured":"Wong PTY, Wong VC-N. Prevalence and characteristics of vaccination triggered seizures in Dravet syndrome in Hong Kong: A retrospective study. Pediatr Neurol. 2016;58:41\u20137.","journal-title":"Pediatr Neurol"},{"key":"3772_CR7","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.pediatrneurol.2013.09.016","volume":"50","author":"N Zamponi","year":"2014","unstructured":"Zamponi N, Passamonti C, Petrelli C, Veggiotti P, Baldassari C, Verrotti A, et al. Vaccination and occurrence of seizures in SCN1A mutation-positive patients: a multicenter Italian study. Pediatr Neurol. 2014;50:228\u201332.","journal-title":"Pediatr Neurol"},{"key":"3772_CR8","doi-asserted-by":"publisher","first-page":"4437","DOI":"10.3390\/cimb46050269","volume":"46","author":"E Stawicka","year":"2024","unstructured":"Stawicka E, Zieli\u0144ska A, G\u00f3rka-Skoczylas P, Kanabus K, Tataj R, Mazurczak T, et al. SCN1A-Characterization of the Gene\u2019s variants in the Polish cohort of patients with Dravet syndrome: one center experience. Curr Issues Mol Biol. 2024;46:4437\u201351.","journal-title":"Curr Issues Mol Biol"},{"issue":"Suppl 3","key":"3772_CR9","first-page":"S2","volume":"60","author":"D Mei","year":"2019","unstructured":"Mei D, Cetica V, Marini C, Guerrini R. Dravet syndrome as part of the clinical and genetic spectrum of sodium channel epilepsies and encephalopathies. Epilepsia. 2019;60(Suppl 3):S2\u20137.","journal-title":"Epilepsia"},{"key":"3772_CR10","unstructured":"The Genetic Facets of Dravet Syndrome. Recent Insights [Internet]. [cited 2024 Nov 22]. Available from: https:\/\/www.annchildneurol.org\/journal\/view.php?number=1351"},{"key":"3772_CR11","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1111\/epi.13889","volume":"58","author":"D Steel","year":"2017","unstructured":"Steel D, Symonds JD, Zuberi SM, Brunklaus A. Dravet syndrome and its mimics: beyond SCN1A. Epilepsia. 2017;58:1807\u201316.","journal-title":"Epilepsia"},{"key":"3772_CR12","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/epi.17239","volume":"63","author":"SM Zuberi","year":"2022","unstructured":"Zuberi SM, Wirrell E, Yozawitz E, Wilmshurst JM, Specchio N, Riney K, et al. ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: position statement by the ILAE task force on nosology and definitions. Epilepsia. 2022;63:1349\u201397.","journal-title":"Epilepsia"},{"key":"3772_CR13","doi-asserted-by":"publisher","first-page":"e1310","DOI":"10.1542\/peds.2015-1807","volume":"136","author":"YW Wu","year":"2015","unstructured":"Wu YW, Sullivan J, McDaniel SS, Meisler MH, Walsh EM, Li SX, et al. Incidence of Dravet syndrome in a US population. Pediatrics. 2015;136:e1310\u20131315.","journal-title":"Pediatrics"},{"key":"3772_CR14","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1111\/epi.17866","volume":"65","author":"J Sullivan","year":"2024","unstructured":"Sullivan J, Ben\u00edtez A, Roth J, Andrews JS, Shah D, Butcher E, et al. A systematic literature review on the global epidemiology of Dravet syndrome and Lennox-Gastaut syndrome: prevalence, incidence, diagnosis, and mortality. Epilepsia. 2024;65:1240\u201363.","journal-title":"Epilepsia"},{"key":"3772_CR15","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.3390\/jcm10091903","volume":"10","author":"J Paprocka","year":"2021","unstructured":"Paprocka J, Lewandowska A, Zieli\u0144ski P, Kurczab B, Emich-Widera E, Mazurczak T. Dravet Syndrome-The Polish family\u2019s perspective study. J Clin Med. 2021;10:1903.","journal-title":"J Clin Med"},{"key":"3772_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/ijms25010031","volume":"25","author":"H-C Fan","year":"2023","unstructured":"Fan H-C, Yang M-T, Lin L-C, Chiang K-L, Chen C-M. Clinical and genetic features of Dravet syndrome: A prime example of the role of precision medicine in genetic epilepsy. Int J Mol Sci. 2023;25:31.","journal-title":"Int J Mol Sci"},{"key":"3772_CR17","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.3390\/jcm12072532","volume":"12","author":"C Gao","year":"2023","unstructured":"Gao C, Pielas M, Jiao F, Mei D, Wang X, Kotulska K, et al. Epilepsy in Dravet Syndrome-Current and future therapeutic opportunities. J Clin Med. 2023;12:2532.","journal-title":"J Clin Med"},{"issue":"Suppl 1","key":"3772_CR18","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.ejpn.2012.04.007","volume":"16","author":"IE Scheffer","year":"2012","unstructured":"Scheffer IE. Diagnosis and long-term course of Dravet syndrome. Eur J Paediatr Neurol. 2012;16(Suppl 1):S5\u20138.","journal-title":"Eur J Paediatr Neurol"},{"key":"3772_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.yebeh.2017.06.031","volume":"74","author":"N Villas","year":"2017","unstructured":"Villas N, Meskis MA, Goodliffe S. Dravet syndrome: characteristics, comorbidities, and caregiver concerns. Epilepsy Behav. 2017;74:81\u20136.","journal-title":"Epilepsy Behav"},{"key":"3772_CR20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/dmcn.13591","volume":"60","author":"L Lagae","year":"2018","unstructured":"Lagae L, Brambilla I, Mingorance A, Gibson E, Battersby A. Quality of life and comorbidities associated with Dravet syndrome severity: a multinational cohort survey. Dev Med Child Neurol. 2018;60:63\u201372.","journal-title":"Dev Med Child Neurol"},{"key":"3772_CR21","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.ejpn.2019.02.014","volume":"23","author":"A Strzelczyk","year":"2019","unstructured":"Strzelczyk A, Kalski M, Bast T, Wiemer-Kruel A, Bettendorf U, Kay L, et al. Burden-of-illness and cost-driving factors in Dravet syndrome patients and carers: A prospective, multicenter study from Germany. Eur J Paediatr Neurol. 2019;23:392\u2013403.","journal-title":"Eur J Paediatr Neurol"},{"key":"3772_CR22","doi-asserted-by":"publisher","first-page":"109726","DOI":"10.1016\/j.yebeh.2024.109726","volume":"154","author":"A Postma","year":"2024","unstructured":"Postma A, Minderhoud CA, Otte WM, Jansen FE, Gunning WB, Verhoeven JS, et al. Understanding neurodevelopmental trajectories and behavioral profiles in SCN1A-related epilepsy syndromes. Epilepsy Behav. 2024;154:109726.","journal-title":"Epilepsy Behav"},{"key":"3772_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.pediatrneurol.2017.01.025","volume":"68","author":"EC Wirrell","year":"2017","unstructured":"Wirrell EC, Laux L, Donner E, Jette N, Knupp K, Meskis MA, et al. Optimizing the diagnosis and management of Dravet syndrome: recommendations from a North American consensus panel. Pediatr Neurol. 2017;68:18\u2013e343.","journal-title":"Pediatr Neurol"},{"key":"3772_CR24","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s40263-019-00666-8","volume":"33","author":"EC Wirrell","year":"2019","unstructured":"Wirrell EC, Nabbout R. Recent advances in the drug treatment of Dravet syndrome. CNS Drugs. 2019;33:867\u201381.","journal-title":"CNS Drugs"},{"key":"3772_CR25","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1080\/14737175.2020.1801423","volume":"20","author":"A Strzelczyk","year":"2020","unstructured":"Strzelczyk A, Schubert-Bast S. Therapeutic advances in Dravet syndrome: a targeted literature review. Expert Rev Neurother. 2020;20:1065\u201379.","journal-title":"Expert Rev Neurother"},{"key":"3772_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1055\/s-0040-1701694","volume":"51","author":"D Samanta","year":"2020","unstructured":"Samanta D. Changing landscape of Dravet syndrome management: an overview. Neuropediatrics. 2020;51:135\u201345.","journal-title":"Neuropediatrics"},{"key":"3772_CR27","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3390\/biomedicines12061249","volume":"12","author":"A Zieli\u0144ska","year":"2024","unstructured":"Zieli\u0144ska A, Skar\u017cy\u0144ska U, G\u00f3rka-Skoczylas P, Mazurczak T, Ku\u017aniar-Pa\u0142ka A, Kanabus K, et al. How has the treatment of Polish children with Dravet syndrome changed?? Future perspectives. Biomedicines. 2024;12:1249.","journal-title":"Biomedicines"},{"key":"3772_CR28","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.resp.2013.06.026","volume":"189","author":"F Kalume","year":"2013","unstructured":"Kalume F. Sudden unexpected death in Dravet syndrome: respiratory and other physiological dysfunctions. Respir Physiol Neurobiol. 2013;189:324\u20138.","journal-title":"Respir Physiol Neurobiol"},{"key":"3772_CR29","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1111\/dmcn.15553","volume":"65","author":"R Whitney","year":"2023","unstructured":"Whitney R, Sharma S, Ramachandrannair R. Sudden unexpected death in epilepsy in children. Dev Med Child Neurol. 2023;65:1150\u20136.","journal-title":"Dev Med Child Neurol"},{"key":"3772_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.eplepsyres.2016.10.006","volume":"128","author":"MS Cooper","year":"2016","unstructured":"Cooper MS, Mcintosh A, Crompton DE, McMahon JM, Schneider A, Farrell K, et al. Mortality in Dravet syndrome. Epilepsy Res. 2016;128:43\u20137.","journal-title":"Epilepsy Res"},{"key":"3772_CR31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.yebeh.2016.09.007","volume":"64","author":"S Shmuely","year":"2016","unstructured":"Shmuely S, Sisodiya SM, Gunning WB, Sander JW, Thijs RD. Mortality in Dravet syndrome: A review. Epilepsy Behav. 2016;64:69\u201374.","journal-title":"Epilepsy Behav"},{"key":"3772_CR32","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s13023-021-01936-9","volume":"16","author":"T Lo Barco","year":"2021","unstructured":"Lo Barco T, Kuchenbuch M, Garcelon N, Neuraz A, Nabbout R. Improving early diagnosis of rare diseases using natural Language processing in unstructured medical records: an illustration from Dravet syndrome. Orphanet J Rare Dis. 2021;16:309.","journal-title":"Orphanet J Rare Dis"},{"key":"3772_CR33","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1600-0404.2011.01609.x","volume":"125","author":"A Bremer","year":"2012","unstructured":"Bremer A, Lossius MI, Nakken KO. Dravet syndrome\u2013considerable delay in making the diagnosis. Acta Neurol Scand. 2012;125:359\u201362.","journal-title":"Acta Neurol Scand"},{"key":"3772_CR34","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1111\/epi.12303","volume":"54","author":"EC Wirrell","year":"2013","unstructured":"Wirrell EC, Laux L, Franz DN, Sullivan J, Saneto RP, Morse RP, et al. Stiripentol in Dravet syndrome: results of a retrospective U.S. Study. Epilepsia. 2013;54:1595\u2013604.","journal-title":"Epilepsia"},{"key":"3772_CR35","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1111\/dmcn.14186","volume":"61","author":"R Nabbout","year":"2019","unstructured":"Nabbout R, Auvin S, Chiron C, Thiele E, Cross H, Scheffer IE, et al. Perception of impact of Dravet syndrome on children and caregivers in multiple countries: looking beyond seizures. Dev Med Child Neurol. 2019;61:1229\u201336.","journal-title":"Dev Med Child Neurol"},{"key":"3772_CR36","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/epi4.12525","volume":"6","author":"K Silvennoinen","year":"2021","unstructured":"Silvennoinen K, Puvirajasinghe C, Hudgell K, Sidhu MK, Martins Custodio H, Genomics England Research Consortium. Late diagnoses of Dravet syndrome: how many individuals are we missing? Epilepsia Open. 2021;6:770\u20136.","journal-title":"Epilepsia Open"},{"key":"3772_CR37","doi-asserted-by":"publisher","first-page":"156","DOI":"10.5604\/12321966.1141387","volume":"22","author":"J Domaradzki","year":"2015","unstructured":"Domaradzki J. Patient rights, risk, and responsibilities in the genetic era - a right to know, a right not to know, or a duty to know? Ann Agric Environ Med. 2015;22:156\u201362.","journal-title":"Ann Agric Environ Med"},{"key":"3772_CR38","doi-asserted-by":"publisher","first-page":"109193","DOI":"10.1016\/j.yebeh.2023.109193","volume":"142","author":"J Domaradzki","year":"2023","unstructured":"Domaradzki J, Walkowiak D. Emotional experiences of family caregivers of children with Dravet syndrome. Epilepsy Behav. 2023;142:109193.","journal-title":"Epilepsy Behav"},{"key":"3772_CR39","first-page":"e928","volume":"92","author":"JK Nowak","year":"2023","unstructured":"Nowak JK, Walkowiak J. Study designs in medical research and their key characteristics. JMS. 2023;92:e928\u2013928.","journal-title":"JMS"},{"key":"3772_CR40","unstructured":"Handbook_questionnaire_development_2006.pdf [Internet]. [cited 2024 Nov 22]. Available from: https:\/\/www.istat.it\/it\/files\/2013\/12\/Handbook_questionnaire_development_2006.pdf"},{"key":"3772_CR41","doi-asserted-by":"publisher","first-page":"e700","DOI":"10.20883\/medical.e700","volume":"91","author":"N Sawicka-Gutaj","year":"2022","unstructured":"Sawicka-Gutaj N, Gruszczy\u0144ski D, Guzik P, Mostowska A, Walkowiak J. Publication ethics of human studies in the light of the declaration of Helsinki \u2013 a mini-review. JMS. 2022;91:e700\u2013700.","journal-title":"JMS"},{"key":"3772_CR42","first-page":"1410","volume":"10","author":"J Domaradzki","year":"2023","unstructured":"Domaradzki J, Walkowiak D. Caring for children with Dravet syndrome: exploring the daily challenges of family caregivers. Child (Basel). 2023;10:1410.","journal-title":"Child (Basel)"},{"issue":"Suppl 2","key":"3772_CR43","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1528-1167.2011.03012.x","volume":"52","author":"JV Skluzacek","year":"2011","unstructured":"Skluzacek JV, Watts KP, Parsy O, Wical B, Camfield P. Dravet syndrome and parent associations: the IDEA league experience with comorbid conditions, mortality, management, adaptation, and grief. Epilepsia. 2011;52(Suppl 2):95\u2013101.","journal-title":"Epilepsia"},{"key":"3772_CR44","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1177\/1535759719871593","volume":"19","author":"HC Mefford","year":"2019","unstructured":"Mefford HC. The road to diagnosis: shortening the diagnostic odyssey in epilepsy. Epilepsy Curr. 2019;19:307\u20139.","journal-title":"Epilepsy Curr"},{"key":"3772_CR45","unstructured":"Black N, Martineau F, Manacorda T. Diagnostic odyssey for rare diseases: exploration of potential indicators. Policy Innovation Research Unit (PIRU) [Internet]. 2015 [cited 2024 Nov 22]; Available from: http:\/\/www.piru.ac.uk\/assets\/files\/Rare%20diseases%20Final%20report.pdf"},{"key":"3772_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ajmg.a.34351","volume":"158A","author":"F Lim","year":"2012","unstructured":"Lim F, Downs J, Li J, Bao X-H, Leonard H. Barriers to diagnosis of a rare neurological disorder in China\u2013lived experiences of Rett syndrome families. Am J Med Genet A. 2012;158A:1\u20139.","journal-title":"Am J Med Genet A"},{"key":"3772_CR47","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.pedhc.2016.09.002","volume":"31","author":"RM Bendixen","year":"2017","unstructured":"Bendixen RM, Houtrow A. Parental reflections on the diagnostic process for Duchenne muscular dystrophy: A qualitative study. J Pediatr Health Care. 2017;31:285\u201392.","journal-title":"J Pediatr Health Care"},{"key":"3772_CR48","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s13023-019-1233-z","volume":"14","author":"A Morrison","year":"2019","unstructured":"Morrison A, Oussoren E, Friedel T, Cruz J, Yilmaz N. Pathway to diagnosis and burden of illness in mucopolysaccharidosis type VII - a European caregiver survey. Orphanet J Rare Dis. 2019;14:254.","journal-title":"Orphanet J Rare Dis"},{"key":"3772_CR49","volume-title":"Choroby Rzadkie W Polsce: Stan Obecny i Perspektywy","year":"2016","unstructured":"Ga\u0142\u0105zka-Sobotka M, Grabowska E, Gryglewicz J, Libura M, Ma\u0142owicka M, W\u0142adusiuk M, editors. Choroby Rzadkie W Polsce: Stan Obecny i Perspektywy. Warszawa: Uczelnia \u0141azarskiego; 2016."},{"key":"3772_CR50","doi-asserted-by":"publisher","first-page":"375","DOI":"10.12740\/PP\/59103","volume":"50","author":"J Domaradzki","year":"2016","unstructured":"Domaradzki J. Family caregivers\u2019 experiences with healthcare services - a case of huntington disease. Psychiatr Pol. 2016;50:375\u201391.","journal-title":"Psychiatr Pol"},{"key":"3772_CR51","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1750-1172-8-22","volume":"8","author":"M Anderson","year":"2013","unstructured":"Anderson M, Elliott EJ, Zurynski YA. Australian families living with rare disease: experiences of diagnosis, health services use and needs for psychosocial support. Orphanet J Rare Dis. 2013;8:22.","journal-title":"Orphanet J Rare Dis"},{"key":"3772_CR52","doi-asserted-by":"publisher","first-page":"e230","DOI":"10.1212\/NXG.0000000000000230","volume":"4","author":"J Grier","year":"2018","unstructured":"Grier J, Hirano M, Karaa A, Shepard E, Thompson JLP. Diagnostic odyssey of patients with mitochondrial disease: results of a survey. Neurol Genet. 2018;4:e230.","journal-title":"Neurol Genet"},{"key":"3772_CR53","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1186\/s13023-022-02530-3","volume":"17","author":"J Benito-Lozano","year":"2022","unstructured":"Benito-Lozano J, L\u00f3pez-Villalba B, Arias-Merino G, Posada de la Paz M, Alonso-Ferreira V. Diagnostic delay in rare diseases: data from the Spanish rare diseases patient registry. Orphanet J Rare Dis. 2022;17:418.","journal-title":"Orphanet J Rare Dis"},{"key":"3772_CR54","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1186\/s12913-023-09886-7","volume":"23","author":"T Willmen","year":"2023","unstructured":"Willmen T, Willmen L, Pankow A, Ronicke S, Gabriel H, Wagner AD. Rare diseases: why is a rapid referral to an expert center so important? BMC Health Serv Res. 2023;23:904.","journal-title":"BMC Health Serv Res"},{"key":"3772_CR55","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/s41431-024-01604-z","volume":"32","author":"F Faye","year":"2024","unstructured":"Faye F, Crocione C, Anido de Pe\u00f1a R, Bellagambi S, Escati Pe\u00f1aloza L, Hunter A, et al. Time to diagnosis and determinants of diagnostic delays of people living with a rare disease: results of a rare barometer retrospective patient survey. Eur J Hum Genet. 2024;32:1116\u201326.","journal-title":"Eur J Hum Genet"},{"key":"3772_CR56","unstructured":"admin. SHCA publishes a new report on delays to a rare disease diagnosis [Internet]. SHCA. 2023 [cited 2024 Nov 22]. Available from: https:\/\/shca.info\/shca-publishes-a-new-report-on-delays-to-a-rare-disease-diagnosis\/"},{"key":"3772_CR57","doi-asserted-by":"crossref","unstructured":"Fish P, Rare Disease Diagnosis. Lost in the System: The Labyrinth of. 2024 [cited 2024 Nov 22]; Available from: https:\/\/www.emjreviews.com\/flagship-journal\/article\/lost-in-the-system-the-labyrinth-of-rare-disease-diagnosis-j190124\/","DOI":"10.33590\/emj\/DLPH7436"},{"key":"3772_CR58","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s13023-024-03143-8","volume":"19","author":"M Al-Attar","year":"2024","unstructured":"Al-Attar M, Butterworth S, McKay L. A quantitative and qualitative analysis of patient group narratives suggests common biopsychosocial red flags of undiagnosed rare disease. Orphanet J Rare Dis. 2024;19:172.","journal-title":"Orphanet J Rare Dis"},{"key":"3772_CR59","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13023-016-0409-z","volume":"11","author":"C Molster","year":"2016","unstructured":"Molster C, Urwin D, Di Pietro L, Fookes M, Petrie D, van der Laan S, et al. Survey of healthcare experiences of Australian adults living with rare diseases. Orphanet J Rare Dis. 2016;11:30.","journal-title":"Orphanet J Rare Dis"},{"key":"3772_CR60","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13023-017-0622-4","volume":"12","author":"Y Zurynski","year":"2017","unstructured":"Zurynski Y, Deverell M, Dalkeith T, Johnson S, Christodoulou J, Leonard H, et al. Australian children living with rare diseases: experiences of diagnosis and perceived consequences of diagnostic delays. Orphanet J Rare Dis. 2017;12:68.","journal-title":"Orphanet J Rare Dis"},{"key":"3772_CR61","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1136\/adc.2009.171827","volume":"95","author":"MG Bouwman","year":"2010","unstructured":"Bouwman MG, Teunissen QGA, Wijburg FA, Linthorst GE. Doctor Google ending the diagnostic odyssey in lysosomal storage disorders: parents using internet search engines as an efficient diagnostic strategy in rare diseases. Arch Dis Child. 2010;95:642\u20134.","journal-title":"Arch Dis Child"},{"key":"3772_CR62","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s40120-023-00450-3","volume":"12","author":"J Bluvstein","year":"2023","unstructured":"Bluvstein J, Wenniger S. Two perspectives on Dravet syndrome: viewpoints from the clinician and the caregiver. Neurol Ther. 2023;12:343\u201350.","journal-title":"Neurol Ther"},{"key":"3772_CR63","doi-asserted-by":"publisher","first-page":"109603","DOI":"10.1016\/j.yebeh.2023.109603","volume":"151","author":"J Soto Jansson","year":"2024","unstructured":"Soto Jansson J, Bjurulf B, Dellenmark Blom M, Hallb\u00f6\u00f6k T, Reilly C. Diagnosis, epilepsy treatment and supports for neurodevelopment in children with Dravet syndrome: caregiver reported experiences and needs. Epilepsy Behav. 2024;151:109603.","journal-title":"Epilepsy Behav"},{"key":"3772_CR64","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s13023-022-02358-x","volume":"17","author":"A Bauskis","year":"2022","unstructured":"Bauskis A, Strange C, Molster C, Fisher C. The diagnostic Odyssey: insights from parents of children living with an undiagnosed condition. Orphanet J Rare Dis. 2022;17:233.","journal-title":"Orphanet J Rare Dis"},{"key":"3772_CR65","doi-asserted-by":"publisher","first-page":"6456","DOI":"10.3390\/ijerph19116456","volume":"19","author":"J Benito-Lozano","year":"2022","unstructured":"Benito-Lozano J, Arias-Merino G, G\u00f3mez-Mart\u00ednez M, Ancochea-D\u00edaz A, Aparicio-Garc\u00eda A, de la Posada M, et al. Diagnostic process in rare diseases: determinants associated with diagnostic delay. Int J Environ Res Public Health. 2022;19:6456.","journal-title":"Int J Environ Res Public Health"},{"key":"3772_CR66","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1186\/s13023-021-02023-9","volume":"16","author":"D Walkowiak","year":"2021","unstructured":"Walkowiak D, Domaradzki J. Are rare diseases overlooked by medical education? Awareness of rare diseases among physicians in Poland: an explanatory study. Orphanet J Rare Dis. 2021;16:400.","journal-title":"Orphanet J Rare Dis"},{"key":"3772_CR67","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13023-019-1075-8","volume":"14","author":"L Vandeborne","year":"2019","unstructured":"Vandeborne L, van Overbeeke E, Dooms M, De Beleyr B, Huys I. Information needs of physicians regarding the diagnosis of rare diseases: a questionnaire-based study in Belgium. Orphanet J Rare Dis. 2019;14:99.","journal-title":"Orphanet J Rare Dis"},{"key":"3772_CR68","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13023-019-1285-0","volume":"15","author":"E Ramalle-G\u00f3mara","year":"2020","unstructured":"Ramalle-G\u00f3mara E, Dom\u00ednguez-Garrido E, G\u00f3mez-Egu\u00edlaz M, Marzo-Sola ME, Ram\u00f3n-Trapero JL. Gil-de-G\u00f3mez J. Education and information needs for physicians about rare diseases in Spain. Orphanet J Rare Dis. 2020;15:18.","journal-title":"Orphanet J Rare Dis"},{"key":"3772_CR69","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13023-022-02243-7","volume":"17","author":"H Zhang","year":"2022","unstructured":"Zhang H, Xiao Y, Zhao X, Tian Z, Zhang S, Dong D. Physicians\u2019 knowledge on specific rare diseases and its associated factors: a National cross-sectional study from China. Orphanet J Rare Dis. 2022;17:120.","journal-title":"Orphanet J Rare Dis"},{"key":"3772_CR70","doi-asserted-by":"publisher","first-page":"180","DOI":"10.5582\/irdr.2022.01079","volume":"11","author":"A Flores","year":"2022","unstructured":"Flores A, Burgos S, Abarca-Barriga H. Knowledge level of medical students and physicians about rare diseases in Lima, Peru. Intractable Rare Dis Res. 2022;11:180\u20138.","journal-title":"Intractable Rare Dis Res"},{"key":"3772_CR71","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.healthpol.2012.02.003","volume":"105","author":"K Roll","year":"2012","unstructured":"Roll K. The influence of regional health care structures on delay in diagnosis of rare diseases: the case of Marfan syndrome. Health Policy. 2012;105:119\u201327.","journal-title":"Health Policy"},{"key":"3772_CR72","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.healthpol.2012.01.006","volume":"105","author":"CR Blankart","year":"2012","unstructured":"Blankart CR. Does healthcare infrastructure have an impact on delay in diagnosis and survival? Health Policy. 2012;105:128\u201337.","journal-title":"Health Policy"},{"key":"3772_CR73","doi-asserted-by":"publisher","first-page":"14016","DOI":"10.1038\/s41598-024-63962-4","volume":"14","author":"J Domaradzki","year":"2024","unstructured":"Domaradzki J, Walkowiak D. Invisible patients in rare diseases: parental experiences with the healthcare and social services for children with rare diseases. A mixed method study. Sci Rep. 2024;14:14016.","journal-title":"Sci Rep"},{"key":"3772_CR74","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.pop.2004.04.010","volume":"31","author":"AJ Whelan","year":"2004","unstructured":"Whelan AJ, Ball S, Best L, Best RG, Echiverri SC, Ganschow P, et al. Genetic red flags: clues to thinking genetically in primary care practice. Prim Care. 2004;31:497\u2013508. viii.","journal-title":"Prim Care"},{"key":"3772_CR75","doi-asserted-by":"publisher","first-page":"976039","DOI":"10.3389\/fepid.2022.976039","volume":"2","author":"J Pellinen","year":"2022","unstructured":"Pellinen J. Treatment gaps in epilepsy. Front Epidemiol. 2022;2:976039.","journal-title":"Front Epidemiol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03772-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03772-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03772-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T09:05:04Z","timestamp":1747386304000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03772-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3772"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03772-7","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,16]]},"assertion":[{"value":"12 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Ethics and research governance approval were obtained from the PUMS Bioethics Committee (KB \u2013 228\/24). Informed written consent was obtained from all individual participants in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"234"}}